The Medical Letter on Drugs and Therapeutics
A Medical Food for Alzheimer's Disease
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.

Axona (Accera), a “medical food” containing a proprietary formulation of medium-chain triglycerides (>95% caprylic triglyceride), is currently being marketed for the “clinical dietary management of the metabolic processes associated with mild to moderate Alzheimer’s disease.”

LEGAL STATUS OF MEDICAL FOODS —The history of medical foods dates to the early 1970’s when infant formulas were developed for patients with rare inherited metabolic disorders such as phenylketonuria. The Orphan Drug Act of 1988 defines a medical food as “a food which is formulated to be consumed or administered enterally (or orally) under the supervision of a physician and which is intended for the specific dietary management of a disease or condition for which distinctive nutritional requirements, based on recognized scientific principles, are established by medical evaluation.”

In the last two decades, ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: A Medical Food for Alzheimer's Disease
Article code: 1315b
 Electronic, downloadable article - $45
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian